Grace’s SYLOID® XDP mesoporous silica gels are designed to have optimized oil absorption properties, oil desorption rates and density. Thus, oily actives and Self Emulsifying Drug Delivery Systems (SEDDS) can easily be processed into a free-flowing powder that can be further formulated into several oral solid dosage forms (OSDF) like powders, tablets and hard gelatin capsules. These powder dosage formulations can potentially improve stability, bioavailability and patient compliance.